On October 23, 2013, nearly one year later, MAPS resubmitted the PTSD study protocol. It took more than four and a half months for HHS to respond to the newly revised protocol, and the outcome couldn’t have been any more jaw dropping for cannabis advocates. As of March 14, because of a few significant changes in the resubmission, “the proposed study is cleared for the purchase of research grade marijuana from NIDA.” It is as much of a breakthrough for the future hopes of cannabis activists and researchers as it is for MAPS since they have been working hard for over 22 years to push for the start to their marijuana drug development research. All eyes are now on the DEA – the final agency that will ultimately decide where this study will end up. Ryan
Posted on: Sat, 22 Mar 2014 22:21:18 +0000
Trending Topics
Recently Viewed Topics
© 2015